bm-navigation: bm-t1-home-navigation-1

IMAGINE A WORLD IN WHICH CANCER DOESN’T WIN

bm-basic: home-our-science

OUR
MISSION

We are dedicated to developing therapeutic molecules that overcome foundational barriers that prevent patients from living longer, cancer-free lives.

PROGRAMS
bm-basic: home-our-team

OUR
TEAM

We believe that overcoming foundational barriers requires collaboration of vision, scientific rigor, novel approaches and bold thought-leaders who are devoted to a shared mission.

TEAM
bm-basic: home-publications-news

HIBERCELL
NEWS

Explore our company updates, news and publications to learn more about how we are overcoming barriers in cancer.

HiberCell Bolsters Leadership Team with Appointment of Joseph Talamo as Chief Financial Officer and Promotion of Ari Nowacek, M.D., Ph.D., to Chief Business Officer

Read More

HiberCell Announces Acquisition of Biothera Pharmaceuticals’ Imprime PGG Program

Read More

Nature Sponsored Feature – Pioneering the Discovery and Development of Novel Therapeutics to Prevent Metastasis

Read More
VIEW ALL
bm-basic: home-work-with-us

CAREERS

Every day at HiberCell moves us closer to a world in which cancer doesn’t win.  If you share this passion, there may be a role for you on our team.

Learn More
Learn More
Learn More
LEARN MORE

OUR
INVESTORS

We are proud to be supported by some of the world’s most visionary investors in biotechnology. Our investors share our commitment to focus on the most impactful outcomes for patients and their families.